{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:53:16Z","timestamp":1794732796727,"version":"4.9.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,6]]},"abstract":"<jats:p>Accurate information on pregnancy outcomes in women with prosthetic heart valves (PHVs) is essential for preconception counseling and prenatal care. This study aims to determine the maternal and fetal outcomes in women with PHVs. A total of 138 pregnant women with PHVs admitted into a tertiary center between November 2007 and February 2020 were included in the study, and the data were analyzed retrospectively. Patients were divided into the mechanical heart valves (MHVs) group, 118 patients with MHVs, and the tissue heart valves (THVs) group, 20 patients with THVs. The 2 groups were compared. There was 1 maternal death in the MHV group patients (0.8%). There was no difference between the 2 groups regarding maternal mortality (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20051.000), valve thrombosis (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.376), and hemorrhagic events (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.692). Only 66.9% of patients in the MHV group had a live birth compared to the live birth rate of 100% in the THV (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005\n                           <jats:italic toggle=\"yes\">=<\/jats:italic>\u2005.002). Mechanical valve thrombosis (MVT) occurred in 3.2% of patients who used warfarin only; no MVT occurred in patients using a regimen called \u201csequential therapy\u201d, which utilizes low-molecular-weight heparin (LMWH) during the 1st trimester and warfarin during the 2nd and 3rd trimesters. MVT occurred in 33.3% of patients using LMWH throughout gestation (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). The difference was statistically significant. Compared to patients using other regimens, the patients using the regimen of \u201cwarfarin only \u201d was correlated with the highest rate of miscarriage (38.1%, 3.4%, and 16.7%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). Women with MHVs have a lower rate of live birth. The anticoagulation regimen of \u201csequential therapy\u201d was superior to other regimens in terms of the weighted effects of regimens on maternal MVTs and fetal loss.<\/jats:p>","DOI":"10.1097\/md.0000000000042622","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:01:34Z","timestamp":1749502894000},"page":"e42622","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Pregnancy outcomes in women with prosthetic heart valves: A single-center study in China"],"prefix":"10.1097","volume":"104","author":[{"given":"Dong","family":"Yang","sequence":"first","affiliation":[{"name":"Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaoFeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zeng","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Liang","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianmei","family":"Luo","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyu","family":"Tian","sequence":"additional","affiliation":[{"name":"Center for Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Li","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Han","sequence":"additional","affiliation":[{"name":"Center for Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2754-350X","authenticated-orcid":false,"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250609","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jacc.2013.01.005","article-title":"Adult congenital heart disease incidence and consultation: a survey of general adult cardiologists.","volume":"61","author":"Fernandes","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250609","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00404-011-2137-x","article-title":"Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases.","volume":"285","author":"Hui","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R3-20250609","first-page":"e35","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"R4-20250609","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/AOG.0000000000003719","article-title":"Management of Stillbirth: Obstetric Care Consensus No, 10.","volume":"135","author":"Metz","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R5-20250609","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/1471-0528.13491","article-title":"Prosthetic heart valves in pregnancy, outcomes for women and their babies: a systematic review and meta-analysis.","volume":"122","author":"Lawley","year":"2015","journal-title":"BJOG"},{"key":"R6-20250609","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.115.015242","article-title":"Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC).","volume":"132","author":"van Hagen","year":"2015","journal-title":"Circulation"},{"key":"R7-20250609","doi-asserted-by":"crossref","first-page":"e12292","DOI":"10.1111\/1755-5922.12292","article-title":"Comparison of anticoagulation regimens for pregnant women with prosthetic heart valves: a meta-analysis of prospective studies.","volume":"35","author":"Wang","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"R8-20250609","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/CMC.S36740","article-title":"Maternal and fetal outcomes in pregnant women with a prosthetic mechanical heart valve.","volume":"10","author":"Ayad","year":"2016","journal-title":"Clin Med Insights Cardiol"},{"key":"R9-20250609","doi-asserted-by":"crossref","first-page":"209","DOI":"10.34172\/jcvtr.2020.35","article-title":"Pregnancy outcome in women with mechanical prosthetic heart valvesat their first trimester of pregnancy treated with unfractionated heparin (UFH) or enoxaparin: a randomized clinical trial.","volume":"12","author":"Movahedi","year":"2020","journal-title":"J Cardiovasc Thorac Res"},{"key":"R10-20250609","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5606\/tgkdc.dergisi.2018.15016","article-title":"Anticoagulation therapy in pregnant women with mechanical heart valve.","volume":"26","author":"\u0130\u015fcan","year":"2018","journal-title":"Turk Gogus Kalp Damar Cerrahisi Derg"},{"key":"R11-20250609","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/1471-0528.14478","article-title":"Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system.","volume":"124","author":"Vause","year":"2017","journal-title":"BJOG"},{"key":"R12-20250609","first-page":"448","article-title":"Pregnancy with prosthetic heart valves - 30 years\u2019 nationwide experience in Denmark.","volume":"40","author":"Sillesen","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"R13-20250609","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.amjcard.2009.06.040","article-title":"Use of low molecular weight heparin in pregnant women with mechanical heart valves.","volume":"104","author":"Yinon","year":"2009","journal-title":"Am J Cardiol"},{"key":"R14-20250609","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1160\/TH04-06-0337","article-title":"Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy.","volume":"92","author":"Oran","year":"2004","journal-title":"Thromb Haemost"},{"key":"R15-20250609","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1471-0528.2009.02299.x","article-title":"Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin.","volume":"116","author":"McLintock","year":"2009","journal-title":"BJOG"},{"key":"R16-20250609","doi-asserted-by":"crossref","first-page":"e000953","DOI":"10.1161\/JAHA.114.000953","article-title":"Heart valve prostheses in pregnancy: outcomes for women and their infants.","volume":"3","author":"Lawley","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 1","key":"R17-20250609","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0049-3848(19)30365-2","article-title":"Pregnancy outcomes in women with mechanical prosthetic heart valves.","volume":"181","author":"Arya","year":"2019","journal-title":"Thromb Res"},{"key":"R18-20250609","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14779072.5.4.753","article-title":"Pregnancy and thrombophilia.","volume":"5","author":"Patnaik","year":"2007","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R19-20250609","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5603\/KP.2019.0049","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.","volume":"77","author":"Regitz-Zagrosek","year":"2019","journal-title":"Kardiol Pol"},{"key":"R20-20250609","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.jacc.2017.03.605","article-title":"Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves.","volume":"69","author":"Steinberg","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R21-20250609","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2011.10.899","article-title":"Mechanical aortic valve replacement in young women planning on pregnancy: maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol.","volume":"59","author":"De Santo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250609","doi-asserted-by":"crossref","first-page":"933","DOI":"10.12669\/pjms.37.4.3924","article-title":"Continued use of Warfarin in lower dose has safe maternal and neonatal outcomes in pregnant women with Prosthetic Heart Valves.","volume":"37","author":"Nadeem","year":"2021","journal-title":"Pak J Med Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:01:41Z","timestamp":1749502901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":22,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042622","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}